Search by Drug Name or NDC

    NDC 59676-0604-14 ERLEADA 240 mg/1 Details

    ERLEADA 240 mg/1

    ERLEADA is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Janssen Products, LP. The primary component is APALUTAMIDE.

    Product Information

    NDC 59676-0604
    Product ID 59676-604_0e3961a5-725a-f825-e063-6394a90ad85d
    Associated GPIs
    GCN Sequence Number 084444
    GCN Sequence Number Description apalutamide TABLET 240 MG ORAL
    HIC3 V1J
    HIC3 Description ANTINEOPLASTIC - ANTIANDROGENIC AGENTS
    GCN 53749
    HICL Sequence Number 044773
    HICL Sequence Number Description APALUTAMIDE
    Brand/Generic Brand
    Proprietary Name ERLEADA
    Proprietary Name Suffix n/a
    Non-Proprietary Name Apalutamide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 240
    Active Ingredient Units mg/1
    Substance Name APALUTAMIDE
    Labeler Name Janssen Products, LP
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA210951
    Listing Certified Through 2025-12-31

    Package

    NDC 59676-0604-14 (59676060414)

    NDC Package Code 59676-604-14
    Billing NDC 59676060414
    Package 1 BLISTER PACK in 1 CARTON (59676-604-14) / 14 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 2023-02-17
    NDC Exclude Flag N
    Pricing Information N/A